BRIEF published on 12/02/2025 at 07:35, 9 months 10 days ago HERIGE et Hoffmann Green Cement renforcent leur partenariat Empreinte Carbone Partenariat HERIGE Hoffmann Green Béton
BRIEF published on 12/02/2025 at 07:35, 9 months 10 days ago HERIGE and Hoffmann Green Cement strengthen their partnership Partnership Carbon Footprint Concrete HERIGE Hoffmann Green
BRIEF published on 12/02/2025 at 07:35, 9 months 10 days ago Reprise et Réorganisation de CARMAT : Procédure de Redressement Financement Liquidation Redressement Judiciaire Plan De Cession CARMAT SAS
BRIEF published on 12/02/2025 at 07:35, 9 months 10 days ago CARMAT Takeover and Reorganization: Restructuring Procedure Funding Liquidation Judicial Reorganization Transfer Plan CARMAT SAS
BRIEF published on 12/02/2025 at 07:05, 9 months 10 days ago Holcim Expands Circular Construction with Strategic Acquisitions in Europe Acquisitions Europe Holcim Recycling Circular Construction
BRIEF published on 12/02/2025 at 07:05, 9 months 10 days ago Holcim renforce sa construction circulaire grâce à des acquisitions stratégiques en Europe Acquisitions Europe Holcim Recyclage Construction Circulaire
BRIEF published on 12/02/2025 at 07:05, 9 months 10 days ago QNX Secures Major Deal with Leading Chinese Automaker for Luxury EVs Cost Savings QNX Software-Defined Audio Chinese Automaker Luxury Electric Vehicles
BRIEF published on 12/02/2025 at 07:05, 9 months 10 days ago QNX conclut un accord majeur avec un grand constructeur automobile chinois pour des véhicules électriques de luxe Réduction Des Coûts Audio Défini Par Logiciel QNX Constructeur Automobile Chinois Véhicules Électriques De Luxe
BRIEF published on 12/02/2025 at 07:05, 9 months 10 days ago Aelis Farma lance un essai clinique de Phase 2B pour AEF0217 chez les personnes avec trisomie 21 Essai Clinique Aelis Farma CB1-SSi Trisomie 21 AEF0217
BRIEF published on 12/02/2025 at 07:05, 9 months 10 days ago Aelis Farma launches a Phase 2B clinical trial for AEF0217 in people with Down syndrome Clinical Trial Aelis Farma CB1-SSi AEF0217 Down Syndrome
Published on 09/12/2026 at 02:35, 1 day ago Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 1 day 4 hours ago Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 21:25, 1 day 5 hours ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 1 day 10 hours ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/12/2026 at 17:50, 9 hours 28 minutes ago New Delhi Marks UN Day for South-South Cooperation with Push to Scale Dryland Innovation Across the Global South
Published on 09/12/2026 at 07:30, 19 hours 48 minutes ago NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Published on 09/11/2026 at 22:15, 1 day 5 hours ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 1 day 5 hours ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 1 day 7 hours ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 07:00, 1 day 20 hours ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 1 day 20 hours ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 2 days 7 hours ago Availability of the 2026 Interim Financial Report
